| Valerie Long, NURSE PRACTITIONER | |
|
501 S Chestnut St, Aberdeen, MS 39730-3336 | |
| (662) 369-6131 | |
| (662) 369-4588 |
| Full Name | Valerie Long |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 501 S Chestnut St, Aberdeen, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134397961 | NPI | - | NPPES |
| 00115237 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R130110 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Valerie Long, NURSE PRACTITIONER 501 S Chestnut St, Aberdeen, MS 39730-3336 Ph: (662) 369-6131 | Valerie Long, NURSE PRACTITIONER 501 S Chestnut St, Aberdeen, MS 39730-3336 Ph: (662) 369-6131 |
News Archive
Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
Kaiser Health News reports that a lawsuit unsealed this week alleges that a national hospice company committed Medicare fraud by improperly cycling patients through nursing homes. In the meantime, a N.Y. prosecutor is investigating a hospital's management practices.
ChanTest, the leading CRO expert in ion channels and nonclinical cardiac safety testing, announces funding of a Phase II SBIR grant. ChanTest will use the grant from the National Heart Lung & Blood Institute to optimize drug safety and discovery assays using stem cell-derived human cardiomyocytes
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
› Verified 3 days ago
Mrs. Nina P Jurney, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 502 Jackson St, Suite 4, Aberdeen, MS 39730 Phone: 662-369-9945 Fax: 662-304-4007 | |
Lisa B Elgin, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 403 S Chestnut St, Aberdeen, MS 39730 Phone: 662-369-9500 Fax: 662-369-0260 | |
Lindsey R Chandler, CFNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 501 S Chestnut St, Aberdeen, MS 39730 Phone: 662-369-6110 | |
Vanessa N Satterwhite, DNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 200 E Commerce St, Aberdeen, MS 39730 Phone: 662-813-5135 Fax: 662-813-5137 | |
Mrs. Amy B Joslin, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 S Chestnut St, Aberdeen, MS 39730 Phone: 662-369-2455 | |
Candace Nicole Polite, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Ms 8 Suite 1, Aberdeen, MS 39730 Phone: 310-482-9203 |